Majchrzak K, Hentschel E, Honzke K, Geithe C, von Maltzahn J
Front Cell Dev Biol. 2024; 12:1378548.
PMID: 39050890
PMC: 11266305.
DOI: 10.3389/fcell.2024.1378548.
Saoud C, Dermawan J, Sharma A, Tap W, Wexler L, Antonescu C
Genes Chromosomes Cancer. 2024; 63(5):e23238.
PMID: 38722224
PMC: 11664927.
DOI: 10.1002/gcc.23238.
Martin-Giacalone B, Li H, Scheurer M, Casey D, Dugan-Perez S, Marquez-Do D
JAMA Netw Open. 2024; 7(3):e244170.
PMID: 38546643
PMC: 10979319.
DOI: 10.1001/jamanetworkopen.2024.4170.
Sun N, Yang Y, Wang S, Zhang J, Gui J, Tai J
Pediatr Investig. 2021; 5(2):106-111.
PMID: 34179706
PMC: 8212716.
DOI: 10.1002/ped4.12278.
Bauer J, Cuvelier N, Ragab N, Simon-Keller K, Nitzki F, Geyer N
Oncogene. 2021; 40(31):4955-4966.
PMID: 34172934
PMC: 8342309.
DOI: 10.1038/s41388-021-01904-4.
Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup.
Kommoss F, Stichel D, Mora J, Esteller M, Jones D, Pfister S
Mod Pathol. 2021; 34(8):1558-1569.
PMID: 33846547
PMC: 8295035.
DOI: 10.1038/s41379-021-00804-y.
Pharmacologic Inhibition of Ezrin-Radixin-Moesin Phosphorylation is a Novel Therapeutic Strategy in Rhabdomyosarcoma.
Proudfit A, Bhunia N, Pore D, Parker Y, Lindner D, Gupta N
Sarcoma. 2020; 2020:9010496.
PMID: 33005093
PMC: 7508224.
DOI: 10.1155/2020/9010496.
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.
Fanzani A, Poli M
Int J Mol Sci. 2017; 18(8).
PMID: 28783123
PMC: 5578108.
DOI: 10.3390/ijms18081718.
Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma.
Robbins K, Stabley D, Holbrook J, Sahraoui R, Sadreameli A, Conard K
Am J Med Genet A. 2016; 170(12):3197-3206.
PMID: 27589201
PMC: 5130350.
DOI: 10.1002/ajmg.a.37949.
Pediatric Rhabdomyosarcoma.
Shern J, Yohe M, Khan J
Crit Rev Oncog. 2015; 20(3-4):227-43.
PMID: 26349418
PMC: 5486973.
DOI: 10.1615/critrevoncog.2015013800.
Uncovering metabolism in rhabdomyosarcoma.
Monti E, Fanzani A
Cell Cycle. 2015; 15(2):184-95.
PMID: 26209235
PMC: 4825834.
DOI: 10.1080/15384101.2015.1071746.
MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.
Faggi F, Codenotti S, Poliani P, Cominelli M, Chiarelli N, Colombi M
PLoS One. 2015; 10(6):e0130287.
PMID: 26086601
PMC: 4472524.
DOI: 10.1371/journal.pone.0130287.
The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities.
Stewart E, Federico S, Karlstrom A, Shelat A, Sablauer A, Pappo A
Dev Biol. 2015; 411(2):287-293.
PMID: 26068307
PMC: 4600003.
DOI: 10.1016/j.ydbio.2015.03.001.
Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma.
Venkatramani R, Triche T, Wang L, Shimada H, Mascarenhas L
J Pediatr Hematol Oncol. 2015; 37(6):e356-60.
PMID: 26056800
PMC: 4506202.
DOI: 10.1097/MPH.0000000000000382.
IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.
Wan X, Yeung C, Heske C, Mendoza A, Helman L
Neoplasia. 2015; 17(4):358-66.
PMID: 25925378
PMC: 4415145.
DOI: 10.1016/j.neo.2015.03.001.
Clonality and evolutionary history of rhabdomyosarcoma.
Chen L, Shern J, Wei J, Yohe M, Song Y, Hurd L
PLoS Genet. 2015; 11(3):e1005075.
PMID: 25768946
PMC: 4358975.
DOI: 10.1371/journal.pgen.1005075.
Pediatric solid tumor genomics and developmental pliancy.
Chen X, Pappo A, Dyer M
Oncogene. 2015; 34(41):5207-15.
PMID: 25639868
PMC: 4522402.
DOI: 10.1038/onc.2014.474.
Pyrosequencing for accurate imprinted allele expression analysis.
Yang B, Damaschke N, Yao T, McCormick J, Wagner J, Jarrard D
J Cell Biochem. 2015; 116(7):1165-70.
PMID: 25581900
PMC: 4880354.
DOI: 10.1002/jcb.25081.
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.
Shern J, Chen L, Chmielecki J, Wei J, Patidar R, Rosenberg M
Cancer Discov. 2014; 4(2):216-31.
PMID: 24436047
PMC: 4462130.
DOI: 10.1158/2159-8290.CD-13-0639.
Early life factors and risk of childhood rhabdomyosarcoma.
Shrestha A, Ritz B, Ognjanovic S, Lombardi C, Wilhelm M, Heck J
Front Public Health. 2013; 1:17.
PMID: 24350186
PMC: 3854857.
DOI: 10.3389/fpubh.2013.00017.